Thursday 12 November 2009, Bridgewater Hall, Manchester, 9.30am - 4.30pm

Agenda

8.45 – Registration open / Networking (45 mins)

9.30 – Sir David Henshaw, Chairman NHS North West SHA / NHS (20 mins)

9.50 – Gail Richards, Chief Executive Oldham PCT / NHS (20 mins)

10.10 – Kevin Pritchard, Director GM Commissioning Business Service / NHS (15 mins)

10.25 – Linda Magee, Chief Operating Officer MAHSC Manchester Academic Health Science Centre / NHS & Academia (20 mins)

10.45 – Panel Discussion (15 mins)

11.00 – Coffee & Networking (30 mins)

11.30 – Jackie Oldham, Director MIMIT / NHS & Academia (20 mins)

11.50 – Margaret Parton, Chief Executive NTAC / NHS (20 mins)

12.10 – Novo Nordisk / Salford Royal Foundation Trust / NHS (20 mins)

12.30 – Lunch & Networking (60 mins)

1.30 – Dr John Stageman, European VP Scientific Affairs Astra Zeneca, Chair Steering Committee Bionow NWRDA (20 mins) / Industry stakeholder engagement

1.50 – Mirella Marlow, Associate Director NICE / NHS (20 mins)

2.10 – Frank Nigriello, Unipart / Leading Improvement (20 mins)

2.25 – Professor Bernard Crump, Chief Executive, NHS Institute Innovation & Improvement / NHS (20 mins)

2.45 – Coffee & Networking (30 mins)

3.15 – Richard Deed, Trustech Northwest Innovation Hub / NHS  (20 mins)

3.35 – Panel Interactive Discussion (25 mins)

4.00 – Networking & Appointment making (30 mins)

4.30 – Event Close

               
The quality objectives set by ‘High Quality Care for All’ will only be met by enhancing and developing our ability to adopt and share innovation. This is why Lord Darzi’s report promised extra funds and support for innovation throughout the NHS, to augment the wealth of exciting projects which are already underway. Similarly, the only way we are going to meet the challenges of a strained economy is through innovation and by improving quality. Innovation will be driven regionally by Strategic Health Authorities, who now have a legal duty to promote and reward innovation. NHS North West’s vision is to create a culture where innovation is expected, supported and celebrated.  A new regional infrastructure will enable the formation of strong partnerships between the NHS, industry, NGO’s and academia, helping to develop solutions, pilots and evaluate new technology. Service innovation will also be strongly supported in this new structure.  

Aimed Outcomes             

Understand what does Darzi mean by ‘legal duty to innovate’

Share with your peers how you and your organisation has already fulfilled this statutory requirement and how you intend to innovate in the future - both at the event and through iReport 

Have an input into how the Regional Innovation Funds (RIF’s) should be allocated along the areas of

1. Service Innovation

2. Healthcare delivery

3. Health Improvement

4. Patient Empowerment / engagement Contribute to future strategy and  take ownership of the end conclusion

Establish co-collaborative partnerships to drive innovation

Objectives

• The 3 B's - from Bench to Bedside to Boardroom success 

• Transfer knowledge. Share best practice. Debate and discuss experiences 

• Raise awareness

• Showcase live projects and pilots

• Offer key influencers and decision makers across the NHS, Academia, and Public Sector related bodies the opportunity to learn, discuss, experience and commission innovation

• Promote a fast track approach to adopting innovation for patient care

• Clearly define each sectors role toward the continuation of UK Plc

• WIBGI / Blue sky thinking
  

Format

• High profile speakers sharing knowledge and disseminating strategy

• Innovation Showcase Presentations / WIBGI Wouldn't It Be Good If

• NHS Surgery Zone for immediate partnership building

• VIP Zone / Very Important Projects

• VIP Leaders / Important Leaders Zone

Benefits of Attending

• Learn about how the Darzi Next Stage Review is changing the current UK health agenda 

• Learn about the North West’s new innovation framework / innovation fund

• Find out what UK Plc means to the region and what part you can play

• Understand how the UK health departments are developing interdependent relationships, breaking down barriers, getting and fostering cultural and organisational changes

• Find out how NGO’s are delivering Expert Patient programmes

• Hear from the grass roots level about ‘what good looks like’

• Look at the role of social marketing in highlighting important personal health issues working with LA’s

• Discuss issues on renewed levels of trust needed to innovate, for partnerships to turn from suboptimal relationships

• Find out how we can reduce health inequalities and eliminate postcode lottery to ensure everyone receives the best healthcare

• Understand what roles technology plays in innovation

• See why Lean methodologies are helping trusts reach targets

• Discover Joint Working models to meet cardiovascular and COPD needs of patients and reducing and treating diabetes

• Hear how World Class Commissioning can help you to innovate

• Learn how leaders contingency plans for Swine Flu uses innovative technology

• Identify where your drugs budget is going and innovate to reduce costs

• Understand the importance of innovating across all 8 Clinical Pathways

•  Find out what innovation means to Chronic Illnesses and Long Term Conditions pathways  like Arthritis & Diabetes

Who should attend

• NHS Chief Executives / Chair / Directors

• Directors of Finance / Procurement / Commissioning / Business Development

• Directors of Nursing

• Directors of Commissioning / Heads of Commissioning

• Medical / Clinical Directors

• Directors of Publlic Health / Public Health Leads

• Directors of Communicatons / Communication Leads

• Directors of Provider Services

• Heads of National/Regional Public Health Groups

• Heads of Treatment and Prevention

• Health Promotion Professionals / Senior Consultants, Clinicians

• Local Authority Management from Band 7 to Board executive

• Third sector Leaders Directors

• Private sector Leaders and Directors

• All those interested in collaborative, interdependent partnerships

• Professionals required to fulfil the NHS Legal Duty to Innovate